Vanrx’s SA25 Aseptic Filling Workcell and Microcell Vial Filler have both been designed to reduce the risks of gene therapy filling. The advanced automation of these systems designs out sources of human interventions in conventional systems, allowing them to be completely closed with no glove ports.
With Vanrx, customers are able to completely close their process from end-to-end and achieve the highest levels of quality and safety. In fact, gene therapy CDMO FUJIFILM Diosynth graded the SA25 Aseptic Filling Workcell far above the alternatives because of various factors, including the hazard contact pathway (only through the flowpath and into the vial) and the use of press-fit vial closures with integrated stoppers.